Showing results (281-290 of 1,298) with videos related to
Sort By:
Pageof 130
Stroke|April 20, 2021
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-AnalysisZien Zhou, Meg J Jardine, Qiang Li, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 24, 2020
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS ProgramBrendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.JAMA Cardiology|December 10, 2025
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial: Interleukin-6 Inhibition and Atherosclerotic Event Rate ReductionPaul M Ridker, Florian M M Baeres, Anders Hveplund, et al.The Medical Journal of Australia|September 23, 2009
Gaps in cardiovascular disease risk management in Australian general practiceRuth J Webster, Emma L Heeley, David P Peiris, et al.Nephrology (Carlton, Vic.)|May 15, 2007
Decision-making about suitability for kidney transplantation: Results of a national survey of Australian nephrologistsAlan Cass, Joan Cunningham, Kate Anderson, et al.Diabetes Care|December 4, 2014
Efficacy and safety of canagliflozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetesBruce Neal, Vlado Perkovic, Dick de Zeeuw, et al.Diabetes, Obesity & Metabolism|February 15, 2022
Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trialJennifer Y Barraclough, Jie Yu, Gemma A Figtree, et al.The Lancet. Rheumatology|January 17, 2024
The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS ProgramJingWei Li, Sunil V Badve, Zien Zhou, et al.Nephrology (Carlton, Vic.)|December 17, 2004
Barriers to access by Indigenous Australians to kidney transplantation: the IMPAKT studyAlan Cass, Jeannie Devitt, Cilla Preece, et al.Journal of Hypertension|May 20, 2017
Blood pressure among Australian Aboriginal childrenNicholas Larkins, Armando Teixeira-Pinto, Emily Banks, et al.Pageof 130